Cargando…
Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine
The coronavirus pandemic, COVID-19 has a global impact on the lives and livelihoods of people. It is characterized by a widespread infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), where infected patients may develop serious medical complications or even face death. Deve...
Autores principales: | Tan, Rebecca Shu Ling, Hassandarvish, Pouya, Chee, Chin Fei, Chan, Lai Wah, Wong, Tin Wui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020865/ https://www.ncbi.nlm.nih.gov/pubmed/35550778 http://dx.doi.org/10.1016/j.carbpol.2022.119500 |
Ejemplares similares
-
A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers
por: Rasul, Ruhisy Mohd, et al.
Publicado: (2020) -
Critical physicochemical and biological attributes of nanoemulsions for pulmonary delivery of rifampicin by nebulization technique in tuberculosis treatment
por: Shah, Kifayatullah, et al.
Publicado: (2017) -
In silico study on anti-Chikungunya virus activity of hesperetin
por: Oo, Adrian, et al.
Publicado: (2016) -
GSH-sensitive polymeric prodrug: Synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine
por: Luo, Lei, et al.
Publicado: (2022) -
Anti-inflammatory Nanomedicine for Cardiovascular Disease
por: Katsuki, Shunsuke, et al.
Publicado: (2017)